INTENT SOLUTIONS™ ANNOUNCES NEW ADVISORY BOARD MEMBER
Barbara Tardiff to Bring Clinical Practice and Research Operations Knowledge
ATLANTA (November 4, 2016) – Intent Solutions™, creator of the breakthrough medical device technology TAD™, is excited to announce the appointment of Barbara Tardiff, M.D., former vice president, development operations, worldwide head, clinical informatics and innovation at Pfizer, to its Advisory Board. Dr. Tardiff brings a wealth of knowledge from her two decades of clinical practice and experience as a clinical investigator. Over the course of her career she has participated in a broad range of scientific and operational activities related to medical product development, including protocol design, data management, information systems, and interpretation and presentation of study findings. Dr. Tardiff has extensive operational experience in conducting clinical research in collaboration with many of the world’s major pharmaceutical firms. She will advise Intent Solutions on issues including product features and capabilities to ensure it addresses drug development and clinical practice needs.
ATLANTA, GA–(Marketwired – October 26, 2015) – On October 16, 2015, Health Connect South Radio welcomed to the studio Lou Malice and Sam Zamarippa with Intent Solutions, and Tommy Cunningham with NFANT Labs. Host CW Hall led a roundtable discussion with these two Atlanta area health technology companies.
Intent Solutions is a start-up that is developing a device aimed at improving compliance with prescribed medication regimens, as well as helping to improve the likelihood the intended person has access to the medicine. In its early phase of development, Intent Solutions has positioned itself to be an effective tool for pharmaceutical research studies. In these studies, it is vital that participants adhere to the prescribed medication regimen in order to obtain the most effective and accurate test results.
"The Future of Rx Bottles; End of Opioid Crisis?
What if a patient could only access their pills during the time their doctor directed, and received only the exact dosage? The device, TAD, “take as directed” is looking to put a tighter cap on prescription abuse.
The pill bottle of the future, developed by Intent Solutions, pictured left, houses a portable dispenser that contains a disposable vial attached to a pre-programmed reusable electronic device, according to a Palm Beach Post report..."
Click to view TAD image displayed in Times Square
American Pharmacists Association
Intent Solutions introduced a mobile medication dispenser at the recent National Rx Drug Abuse and Heroin Summit. TAD, or "Take As Directed," was developed to stop overdoses, thwart illegal prescription drug sales, and help patients remember to take their medications.
Fingerprint recognition, locks could be coming to pill bottlesATLANTA — Imagine a prescription drug bottle that only can dispense your medication at the exact time you should take it, in the proper amount and only after it scans your fingerprint and confirms your identity.
ATLANTA (March 28, 2016) – A pioneering breakthrough in medical device technology called TAD™, for “Take As Directed,” will be introduced at this month’s National Rx Drug Abuse and Heroin Summit March 28 – 31. The availability of TAD™ to the prescription marketplace brings technological innovation into the ongoing policy discussions surrounding opioid adherence and abuse prevention, as the device successfully eliminates access to all medications at once while at the same time barring access to the medication by anyone other than the patient to whom it was prescribed.
Staff Writer - Atlanta Business Chronicle
March 28th, 2016
Prescription drug abuse recently surpassed auto accidents as the No. 1 cause of injury related deaths in the United States, and a company led by prominent former Georgia State Sen. Sam Zamarripa believes it has a device that can help.
Atlanta-based Intent Solutions' medical device TAD, which stands for "Take As Directed," eliminates access to all of a patient's medications at once while barring access to anyone besides the patient.